Scientific ReportHIVInternational Workshop on Aging & HIV 2021Meeting Report Day 1 | N. Nanditha | by M. MascoliniView Scientific Report
Scientific ReportHIVInternational Workshop on Aging & HIV 2021Meeting Report Day 1 | B. Olieveri-Mui | by M. MascoliniView Scientific Report
Scientific ReportHIVInternational Workshop on Aging & HIV 2021Meeting Report Day 1 | J. Milić | by M. MascoliniView Scientific Report
GBGeorg BehrensMD, PhDVideoHIVManaging HIV Patients With Limited Treatment Options 2021Georg Behrens | Clinical Case #1: New Agents in Patients with Multiple Drug ResistanceView Video
AMGAnna Maria GerettiMD, PhD, FRCPathVideoHIVManaging HIV Patients With Limited Treatment Options 2021Anna Maria Geretti | Epidemiology of Patients with Limited Treatment Options in EuropeView Video
RPRoger ParedesMD, PhDVideoHIVManaging HIV Patients With Limited Treatment Options 2021Roger Paredes | Understanding and Managing Multi-Class ResistanceView Video
CNCClíona Ní CheallaighMB, BAO, BCh, MRCP, PhDVideoHIVManaging HIV Patients With Limited Treatment Options 2021Cliona Ni Cheallaigh | Clinical Case #2: Patient with Immune Non-ResponseView Video
MAMarcus AltfeldMD, DTM&HVideoHIVManaging HIV Patients With Limited Treatment Options 2021Marcus Altfeld | Immune Non-Responders - A Remaining Unmet NeedView Video
ACAndrea CalcagnoMD, DTM&HVideoHIVManaging HIV Patients With Limited Treatment Options 2021Andrea Calcagno | Pharmacological Considerations in Optimizing Care for Patients with Limited Treatment OptionsView Video
DKDaniel KuritzkesMDVideoHIVManaging HIV Patients With Limited Treatment Options 2021Daniel Kuritzkes | Update on Clinical Trials of Drugs for Patients with Limited Treatment OptionsView Video
ACAndrea CalcagnoMD, DTM&HSlidesetHIVManaging HIV Patients With Limited Treatment Options 2021Andrea Calcagno | Pharmacological Considerations in Optimizing Care for Patients with Limited Treatment OptionsView Slideset
AMGAnna Maria GerettiMD, PhD, FRCPathSlidesetHIVManaging HIV Patients With Limited Treatment Options 2021Anna Maria Geretti | Epidemiology of Patients with Limited Treatment Options in EuropeView Slideset
